Microorganisms (Jun 2022)
Recommendations to Improve Tick-Borne Encephalitis Surveillance and Vaccine Uptake in Europe
- Michael Kunze,
- Pavle Banović,
- Petra Bogovič,
- Violeta Briciu,
- Rok Čivljak,
- Gerhard Dobler,
- Adriana Hristea,
- Jana Kerlik,
- Suvi Kuivanen,
- Jan Kynčl,
- Anne-Mette Lebech,
- Lars Lindquist,
- Iwona Paradowska-Stankiewicz,
- Srđan Roglić,
- Dita Smíšková,
- Franc Strle,
- Olli Vapalahti,
- Nenad Vranješ,
- Nataliya Vynograd,
- Joanna Maria Zajkowska,
- Andreas Pilz,
- Andreas Palmborg,
- Wilhelm Erber
Affiliations
- Michael Kunze
- Center for Public Health, Medical University of Vienna, 1090 Vienna, Austria
- Pavle Banović
- Ambulance for Lyme Borreliosis and Other Tick-Borne Diseases, Department of Prevention of Rabies and Other Infectious Diseases, Pasteur Institute Novi Sad, 21000 Novi Sad, Serbia
- Petra Bogovič
- Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525 Ljubljana, Slovenia
- Violeta Briciu
- Department of Infectious Diseases, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, 400348 Cluj-Napoca, Romania
- Rok Čivljak
- University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, Mirogojska 8, 10000 Zagreb, Croatia
- Gerhard Dobler
- National Reference Laboratory for TBEV, Bundeswehr Institute of Microbiology, 80937 Munich, Germany
- Adriana Hristea
- Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020022 Bucharest, Romania
- Jana Kerlik
- Department of Epidemiology, Regional Authority of Public Health in Banská Bystrica, 97556 Banská Bystrica, Slovakia
- Suvi Kuivanen
- Department of Virology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland
- Jan Kynčl
- Department of Infectious Diseases Epidemiology, National Institute of Public Health, Vinohrady, 10000 Prague, Czech Republic
- Anne-Mette Lebech
- Department of Infectious Diseases, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- Lars Lindquist
- Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, 14186 Stockholm, Sweden
- Iwona Paradowska-Stankiewicz
- Department of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health, National Institute of Hygiene—National Research Institute, 00791 Warsaw, Poland
- Srđan Roglić
- University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, Mirogojska 8, 10000 Zagreb, Croatia
- Dita Smíšková
- Department of Infectious Diseases, Second Faculty of Medicine, Charles University, 18081 Prague, Czech Republic
- Franc Strle
- Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525 Ljubljana, Slovenia
- Olli Vapalahti
- Department of Virology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland
- Nenad Vranješ
- Department for Research & Monitoring of Rabies & Other Zoonoses, Pasteur Institute Novi Sad, 21000 Novi Sad, Serbia
- Nataliya Vynograd
- Department of Epidemiology, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine
- Joanna Maria Zajkowska
- Department of Infectious Diseases and Neuroinfections, Medical University of Białystok, 15-540 Białystok, Poland
- Andreas Pilz
- Medical and Scientific Affairs, Pfizer Vaccines, 1210 Vienna, Austria
- Andreas Palmborg
- Medical and Scientific Affairs, Pfizer Vaccines, 19138 Stockholm, Sweden
- Wilhelm Erber
- Medical and Scientific Affairs, Pfizer Vaccines, 1210 Vienna, Austria
- DOI
- https://doi.org/10.3390/microorganisms10071283
- Journal volume & issue
-
Vol. 10,
no. 7
p. 1283
Abstract
There has been an increase in reported TBE cases in Europe since 2015, reaching a peak in some countries in 2020, highlighting the need for better management of TBE risk in Europe. TBE surveillance is currently limited, in part, due to varying diagnostic guidelines, access to testing, and awareness of TBE. Consequently, TBE prevalence is underestimated and vaccination recommendations inadequate. TBE vaccine uptake is unsatisfactory in many TBE-endemic European countries. This review summarizes the findings of a scientific workshop of experts to improve TBE surveillance and vaccine uptake in Europe. Strategies to improve TBE surveillance and vaccine uptake should focus on: aligning diagnostic criteria and testing across Europe; expanding current vaccine recommendations and reducing their complexity; and increasing public education of the potential risks posed by TBEV infection.
Keywords
